Exalenz Biosciences, a Jersey City, N.J.-based GI and liver condition diagnostic medical device development company, has announced the global launch of its BreathID Hp.
The BreathID Hp is designed as a non-invasive, quick and accurate test for the detection of H. pylori.
More Articles on Gastroenterology:
4 GI Devices Receive FDA 510(k) Clearance in May & June
FDA Will Not Require IND for Fecal Microbiota Transplant
Endoscopy Device Market to be Worth $4.3B by 2017